Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis
Elisabeth Simader, Selma Tobudic, Péter Mandl, Helmuth Haslacher, Thomas Perkmann, Thomas Nothnagl, Judith Sautner, Helga Radner, Florian Winkler, Heinz Burgmann, Daniel Mrak, Daniel Aletaha, Stefan Winkler, Stephan Blüml
Topics & Concepts
MedicineSeroconversionRheumatoid arthritisVaccinationImmunologySerologyArthritisImmune systemTiterInternal medicineAntibodyRheumatoid Arthritis Research and TherapiesSARS-CoV-2 and COVID-19 ResearchSpondyloarthritis Studies and Treatments